Cargando…

Targeting non-viral vectors to tumor cells and the tumor microenvironment

Detalles Bibliográficos
Autores principales:	Moura, Vera, Lacerda, Manuela, Figueiredo, Paulo, Corvo, M Luísa, Cruz, M Eugénia M, de Lima, M Conceição P, Simões, Sérgio, Moreira, João N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254993/

Ejemplares similares

The role of the tumor microenvironment in breast cancer progression
por: Min, H, et al.
Publicado: (2005)

Inoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine Model
por: Gregório, Ana C., et al.
Publicado: (2016)

The tumor microenvironment: the involvement of the selectin-selectin-ligand axis in tumor-endothelium interactions
por: Witz, Isaac P
Publicado: (2006)

Tumor microenvironment controls the rate of cancer progression and metastasis
por: Kalluri, Raghu
Publicado: (2010)

Direct activation of STING in the tumor microenvironment with synthetic cyclic dinucleotide derivatives leads to potent and systemic tumor-specific immunity
por: Corrales, Leticia, et al.
Publicado: (2014)

Editorial: The Translational and Therapeutic Potential of the Tumor Microenvironment in Oral Cancer
por: Hunter, Keith D., et al.
Publicado: (2021)

S188: CAR-T CELLS SHAPE THE IMMUNOLOGICAL POTENTIAL OF THE TUMOR MICROENVIRONMENT
por: Frede, Julia, et al.
Publicado: (2023)

Focused ultrasound: an effective technique for unleashing the power of immunotherapy in the tumor microenvironment?
por: Repasky, Elizabeth
Publicado: (2015)

Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings
por: Dobriyan, Alex, et al.
Publicado: (2021)

Viral vectored transmission blocking vaccines against Plasmodium falciparum
por: Kapulu, Melissa C, et al.
Publicado: (2010)

Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings
Publicado: (2022)

S237: THE GENETIC SUBTYPES AND THE TUMOR MICROENVIRONMENT SIGNATURES ARE ASSOCIATED WITH DISTINCT OUTCOMES IN PERIPHERAL T-CELL LYMPHOMA
por: Suehara, Yasuhito, et al.
Publicado: (2023)

Crosstalk between cancer stem cells and the tumor microenvironment drives progression of premalignant oral epithelium
por: Polverini, Peter J., et al.
Publicado: (2023)

Reengineering Tumor Microenvironment with Sequential Interleukin Delivery
por: Figueiredo, Marxa L., et al.
Publicado: (2021)

The PTEN pathway in Tregs functions as a critical driver of the immunosuppressive tumor microenvironment and tolerance to apoptotic cells
por: Sharma, Madhav, et al.
Publicado: (2015)

The Immunomodulatory Effects of Mesenchymal Stem Cell Polarization within the Tumor Microenvironment Niche
por: Rivera-Cruz, Cosette M., et al.
Publicado: (2017)

Effects of Exosomal Viral Components on the Tumor Microenvironment
por: Li, Jing, et al.
Publicado: (2022)

Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment
por: Wallecha, Anu, et al.
Publicado: (2013)

Agonist anti-4-1BB plus neutralizing anti-CTLA-4 or -PD-L1 synergize to promote tumor regression by rescuing dying dysfunctional CD8+ T cells within the tumor microenvironment
por: Horton, Brendan, et al.
Publicado: (2015)

Liposomes as Tools to Improve Therapeutic Enzyme Performance
por: Cruz, Maria Eugénia Meirinhos, et al.
Publicado: (2022)

Therapeutic efficacy of combined blockade of CTLA-4 +/- PD-L1 +/- IDO is associated with re-activation of T cells directly within the tumor microenvironment
por: Spranger, Stefani, et al.
Publicado: (2013)

Growth hormone in the tumor microenvironment
por: Chesnokova, Vera, et al.
Publicado: (2019)

Editorial: Proteoglycans in the Tumor Microenvironment
por: Brunetti, Jlenia, et al.
Publicado: (2022)

Abstracts from the International Meeting on Arboviruses and their Vectors 2019
Publicado: (2019)

Breast tumor heterogeneity: causes and consequences
por: Polyak, K, et al.
Publicado: (2009)

Bispecific costimulatory molecules for activation of tumor-killing lymphocytes
por: Weth, R, et al.
Publicado: (2004)

Molecular characteristics of inherited breast tumors
por: Borg, Å, et al.
Publicado: (2000)

Metabolic reprogramming in tumors: Contributions of the tumor microenvironment
por: Lane, Andrew N., et al.
Publicado: (2019)

The evaluation of prognostic value of serum tumor marker in ovarian tumors
por: Sharief, S, et al.
Publicado: (2015)

Circulating tumor cells and novel biomarkers for prognostic and biological of breast cancer
por: Cristofanilli, M
Publicado: (2005)

A significant role for tumor necrosis factor in Nlrp3 inflammasomeopathies
por: McGeough, M, et al.
Publicado: (2015)

Paediatric renal tumors
por: Towbin, Alexander J
Publicado: (2015)

Editorial: Odontogenic Tumors
por: Mikami, Toshinari, et al.
Publicado: (2022)

The Molecular Pathology of Odontogenic Tumors: Expanding the Spectrum of MAPK Pathway Driven Tumors
por: Guimarães, Letícia Martins, et al.
Publicado: (2021)

Herceptin-sensitivity of HER2-transgenic mouse mammary tumors
por: Schwall, RH, et al.
Publicado: (2003)

Eliminating mesothelioma by AAV-vectored, PD1-based vaccination in the tumor microenvironment
por: Tan, Zhiwu, et al.
Publicado: (2021)

Prevention of breast tumor angiogenesis and metastasis by cytostatic molecules in relevant mouse models
por: Crépin, M, et al.
Publicado: (2003)

Producing and evaluating a novel lentiviral vector for β-thalassaemia gene therapy
por: Bokinni, Y, et al.
Publicado: (2012)

Vector borne pathogens and host complement system: a tangled tale
por: Bhide, M, et al.
Publicado: (2014)

Adenovirus vectors from various serotypes induce distinct cytokine profiles
por: Teigler, JE, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gqlov64517k2stj89ulsketudj